Taiji Group (600129.SH) subsidiary Epinephrine hydrochloride injection passed the consistency evaluation of generic drugs.

News from the Zhitong Finance and Economics APP, Taiji Group (600129.SH) issued an announcement. Recently, the company's controlling subsidiary, Southwest Pharmaceuticals Co., Ltd. (referred to as Southwest Pharmaceuticals), received the "Drug Supplementary Application Approval Notice" from the National Medical Products Administration for the adrenaline hydrochloride injection. Southwest Pharmaceuticals adrenaline hydrochloride injection has passed the evaluation of generic drug quality and efficacy consistency. This drug is mainly used for severe respiratory distress caused by bronchospasm, can quickly relieve allergic shock caused by drugs, and can also be used to prolong the duration of infiltration anesthesia.